Gene: PIF1
Official Full Name: PIF1 5'-to-3' DNA helicaseprovided by HGNC
Gene Summary: This gene encodes a DNA-dependent adenosine triphosphate (ATP)-metabolizing enzyme that functions as a 5' to 3' DNA helicase. The encoded protein can resolve G-quadruplex structures and RNA-DNA hybrids at the ends of chromosomes. It also prevents telomere elongation by inhibiting the actions of telomerase. Alternative splicing and the use of alternative start codons results in multiple isoforms that are differentially localized to either the mitochondria or the nucleus. [provided by RefSeq, Nov 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26225 | PIF1 Knockout cell line (HeLa) | Human | PIF1 | 1:3~1:6 | Negative | Online Inquiry |
KO26226 | PIF1 Knockout cell line (HCT 116) | Human | PIF1 | 1:2~1:4 | Negative | Online Inquiry |
KO26227 | PIF1 Knockout cell line (HEK293) | Human | PIF1 | 1:3~1:6 | Negative | Online Inquiry |
KO26228 | PIF1 Knockout cell line (A549) | Human | PIF1 | 1:3~1:4 | Negative | Online Inquiry |
PIF1 Gene Knockout Cell Lines represent a state-of-the-art tool for investigating the functional roles of the PIF1 helicase, a member of the DEAH-box protein family known for its involvement in DNA replication and repair processes. These genetically engineered cell lines have been meticulously crafted to eliminate the expression of the PIF1 gene, allowing researchers to study the consequences of PIF1 deficiency on cellular functions such as genomic stability, cellular growth, and response to DNA damage.
The PIF1 Gene Knockout Cell Lines operate through homologous recombination techniques, ensuring precise elimination of the PIF1 gene from the cellular genome. This knockout strategy provides a robust platform for elucidating the biological pathways that depend on PIF1 activity, paving the way for groundbreaking discoveries related to cancer biology and other genomic disorders. By examining these cell lines, researchers can generate insights into the molecular mechanisms that underlie DNA replication fidelity and the cellular response to genotoxic stress.
In a scientific setting, the ability to manipulate the PIF1 gene allows for a deeper understanding of its role in maintaining genomic integrity. The implications of this research extend into clinical applications, particularly in the development of targeted therapies for cancers characterized by defective DNA repair mechanisms. Unlike conventional methods that may utilize siRNA or transient transfection approaches, these knockout cell lines provide a stable model, enabling long-term studies and more reproducible results.
The specific advantages of using PIF1 Gene Knockout Cell Lines include the capacity for high-throughput screening, reproducibility of experimental results, and the ability to pair with various downstream assays, such as CRISPR-based gene editing or drug response tests. These features contribute to a clearer understanding of PIF1's role, making it an invaluable asset for any laboratory focused on molecular biology, oncology, or genetic research.
Our company boasts extensive experience in the field of genetic engineering and cell line development, ensuring that our PIF1 Gene Knockout Cell Lines are of the highest quality and precision. By choosing our product, researchers can trust in the excellence and reliability critical for advancing their scientific inquiries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.